Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides

Immunology

Volumn 87, Issue 2, 1996, Pages 179-185

  Partidos, C D ^a   Vohra, P ^a   Steward, M W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEASLES VACCINE; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CYTOTOXICITY; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INTRANASAL DRUG ADMINISTRATION; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030040893     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.462527.x     Document Type: Article

References (38)

1. OBEID E.O., PARTIDOS C.D., HOWARD C.R. & STEWARD M.W. (1995) Protection against Morbillivirus induced encephalitis by immunization with rationally designed synthetic peptide vaccine containing B and T cell epitopes from the fusion protein of measles virus. J Virol 69, 1420.
2. VALERO M.V., AMADOR L.R., GALINDO C. et al. (1993) Vaccination with SPF66 a chemically synthesized vaccine against Plasmodium falciparum malaria in Colombia. Lancet 341, 705.
3. GOOD R.A. & ZAK S.J. (1956) Disturbances in gamma globulin synthesis as 'experiments of nature'. Pediatrics 18, 109.
4. KRETH H.W., TER MEULEN V. & ECKERT G. (1979) Demonstration of HLA restricted killer cells in patients with acute measles. Med Microbiol Immunol 165, 203.
5. LUCAS C.J., BIDDISON W.E., NELSON D.L. & SHAW S. (1982) Killing of measles virus-infected cells by human cytotoxic T cells. Infect Immunol 38, 226.
6. UYTDEHAAG F.G.C.M., VAN BINNENDIJK R.S., KENTER M.J.H. & OSTERUAUS A.D.M.E. (1994) Cytotoxic T lymphocyte responses against measles virus. Curr Top Microbiol Immunol 189, 151.
7. TOWNSEND A. & BODMER H. (1989) Antigen recognition of class I restricted T lymphocytes. Annu Rev Immunol 7, 601.
8. TREANOR J.J., MATTISON H.R., DUMYATI G. et al. (1992) Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 117, 625.
9. ANDERSON E.L., NEWMAN F.K., MAASSAB H.F. & BELSHE R.B. (1992) Evaluation of a cold adapted influenza B/TEXAS/84 reassortant virus (CRB-87) vaccine in young children. J Clin Microbiol 30, 2230.
10. SABIN A.B., ARECHIGA A.F., DE CASTRO J.F., ALBRECHT P., SEVER J.L. & SHEKARCHI I. (1984) Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine; ii Vaccine comparisons and evidence for multiple antibody response. J Am Med Assoc 251, 2363.
11. PARTIDOS C.D. & STEWARD M.W. (1990) Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. J Gen Virol 71, 2099.
12. PARTIDOS C.D., STANLEY C.M. & STEWARD M.W. (1991) Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus. J Gen Virol 72, 1293.
13. k restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein. Viralogy 203, 172.
14. RAGER ZISMAN B., EGAN J.E., KRESS Y. & BLOOM B.R. (1984) Isolation of cold-sensitive mutants of measles virus from persistently infected murine neuroblastoma cells. J Virol 51, 845.
15. GOPAS J., ITZHAKY D., SEGEV Y. et al. (1992) Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblasloma cells. Cancer Immunol Immunother 34, 313.
16. TAMURA S., YAMANAKA A., SHIMOHARA M. et al. (1994) Synergistic action of cholera toxin B subunit (and Escherichia Coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 12, 419.
17. ELSON C.O. & DERTZBAUGH M.T. (1994) Mucosal Adjuvants. In: Handbook of Mucosal Immunology (eds P.L. Ogra, M.E. Lamm, J.R. McGhee, J. Mestecky, W. Strober & J. Bienenstock), p. 391. Academic Press, San Diego, CA.
18. HAJISHENGALLIS G., HOLLINGSHEAD S.K., TOSHIHIKO K. & RUSSELL M.W. (1995) Mucosol immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 154, 4324.
19. LANGERMANN S., PALASZYNSKI S., SADZIENE A., STOVER K.C. & KOENIG S. (1994) Systemic and mucosal immunity induced by BCG vector expressing outer surface protein A of Borrelia Burgdorferi. Nature 372, 552.
20. MOWAT A. & DONACHI A.M. (1991) ISCOMs a novel strategy for mucosal immunization. Immunol Today 12, 383.
21. ISHIOKA G.Y., COLON S., MILES C., GREY H.M. & CHESNUT R.W. (1989) Induction of class I MHC restricted, peptide specific cytolytic T lymphocytes by peptide priming in vitro. J Immunol 143, 1094.
22. DERES K., SCHILD H., WIESMULLER K.H., JUNG G. & RAMMENSEE H.G. (1989) In viva priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342, 561.
23. WIDMANN C., ROMERO P., MARYANSKI J.L., CORRADIN G. & VAEMORI D. (1992) T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I restricted malaria peptides. J Immunol Methods 155, 95.
24. + T cell help. J Immunol 147, 4069.
25. + helper cells. Nature 328, 77.
26. SINGER A. & HODES R.J. (1983) Mechanisms of T cell B cell interaction. Annu Rev Immunol 1, 211.
27. STUHLER G. & WALDEN P. (1993) Collaboration of helper and cytotoxic T lymphocytes. Eur J Immunol 23, 2279.
28. ROCK K.L., GAMBLE S. & ROTHSTEIN L. (1990) Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249, 918.
29. ERARD F., CORTHESY P., NABHOLZ M. et al. (1985) Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin stimulated cytolytic T lymphocyte precursors. J Immunol 134, 1644.
30. SIMON M.M., HOCHGESCHWENDER U., BRUGGER U. & LANDOLFO S. (1986) Monoclonal antibodies to interferon inhibit interleukin 2 dependent induction of growth and maturation in lectin antigen reactive cytolytic T lymphocyte precursors. J Immunol 136, 2755.
31. SETTE A., SIDNEY J., AEBERTSON M. et al. (1990) A novel approach to the generation of high affinity class II binding peptides. J Immunol 145, 1809.
32. PARTIDOS C.D., STANLEY C.M. & STEWARD M.W. (1992) The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides. Eur J Immunol 22, 2675.
33. BOWEN J.C., NAIR S.K., REDDY R. & ROUSE B.T. (1994) Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T lymphocyte responses with non-replicating antigens. Immunology 81, 338.
34. GIZURARSON S., TAMURA S.I., AIZAWA C. & KURATA T. (1992) Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. Vaccine 10, 101.
35. TAMURA S.I., ISHIHARA K., MIYATA K., AIZAWA C. & KURATA T. (1995) Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin. Vaccine 13, 339.
36. NAIR S., BUITING A.M.J., ROUSE R.J.D., VAN ROOIJEN N., HUANG L. & ROUSE B.T. (1995) Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Intern Immunol 7, 679.
37. BANKAMP B., BRINCKMANN U.G., REICH A., NIEWIESK S., TER MEULEN V. & LIEBERT U.G. (1991) Measles virus nucleocapsid protein protects rats from encephalitis. J Virol 65, 1695.
38. NIEWIKSK S., BRINCKMANN U., BANKAMP B., SIRAK S., LIEBERT U.G. & TER MEULEN V. (1993) Susceptibility to measles virus induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. J Virol 67, 75.